Dr. Weeks took these efforts one-step further. He conducted clinical trials of the drink, and had those findings published in a peer-reviewed manuscript.
“I knew when we finished formulating Relarian (the patent pending effective blend in Mini Chill) that it worked to cause relaxation and focus. The next step was conducting trials and submitting my findings to the peer-reviewed process. It’s uncommon in the food and beverage world, but it is the only way to establish your findings as scientific fact. “
The clinical trials, conducted on 60 healthy adults, found that 51 of them experienced increased relaxation and improved mental focus. This research was submitted to The Medical Science Monitor, whose international board of scientists and physicians signed off that the findings were accurate. These findings were then published in the December 2009 issue of the Medical Science Monitor.
Such scientific proof of efficacy is important to a relaxation drink, especially when some of Mini Chill’s competitors are getting bad press for using dangerous ingredients like the sleep hormone, melatonin. In a recent New York Daily News article, Dr. Charles Czeisler of Harvard Medical School was quoted as saying, “Melatonin is a hormone, (Hormones) should not be put in beverages, since the amount people drink often depends on thirst and taste rather than being taken only when needed like any other drug.”
Since the brand’s inception, Mini Chill was never intended to induce sleep, according to Mini Chill founder Steven Panzella, “When I had the idea for Mini Chill, I wanted to make something I could take at work and not have to worry about it interfering with my responsibilities.”
The clinical trials and peer-reviewed process seem to have paid off for Mini Chill and it’s creators. While it seems none of their competitors are immune to the criticism of media outlets calling their brands and products irresponsible or even dangerous, Mini Chill is unscathed by negative press.
